Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
HuidaGene Therapeutics Appoints Alvin Luk as Chief Executive Officer
HuidaGene Therapeutics, a clinical-stage genome-editing company, today announced the appointment of gene therapy industry veteran, […]
Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials
Endo International announced today that its subsidiary Endo Ventures has executed an agreement with MAIA […]
ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth
ElevateBio, a technology-driven company focused on powering the creation of life-transforming cell and gene therapies, […]
Bob Battista Joins Platform Life Sciences as EVP, Chief Strategy & Commercial Officer
Platform Life Sciences, a global impact research organization, has announced the appointment of Bob Battista as […]
Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer and Other Leadership Appointments
Obsidian Therapeutics, a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the […]
Life Biosciences Expands Team with the Appointment of Ming Yang, Ph.D., as SVP of Research and Development
Life Biosciences (“Life Bio”), a biotechnology company advancing innovative cellular rejuvenation platforms to reverse diseases […]
smartbax Announces Seed Financing of €1.2 Million to Develop Next-generation Antibiotics
smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the close […]
Gamida Cell Appoints Terry Coelho as CFO
Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, has announced […]
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX Therapeutics
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge antibody technology innovation […]
Food and Drug Administration (FDA) and Clarivate Extend Material Transfer Agreement for Three Additional Years
Clarivate, a global leader in connecting people and organizations to intelligence they can trust to […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more